A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30+ hematologic malignancies.

Source:http://linkedlifedata.com/resource/pubmed/id/18079362

Blood 2008 Feb 15 111 4 1848-54

Download in:

View as

Triples

General Info

PMID
18079362